Taylor Russell Clyde 4
4 · Cellu Tissue Holdings, Inc. · Filed Jan 28, 2010
Insider Transaction Report
Form 4
Taylor Russell Clyde
DirectorPresident, CEO
Transactions
- Conversion
Common Stock
2010-01-27+15,084→ 15,084 total - Conversion
Common Stock
2010-01-27+602,612→ 602,612 total(indirect: By LLC) - Conversion
Common Stock
2010-01-27+631,927→ 1,328,994 total(indirect: By LLC) - Conversion
Series A Preferred Stock
2010-01-27−15,084→ 0 total→ Common Stock (15,084 underlying) - Award
Employee Stock Option
2010-01-27+69,814→ 69,814 totalExercise: $11.45Exp: 2020-01-27→ Common Stock (69,814 underlying) - Conversion
Common Stock
2010-01-27+618,472→ 618,472 total(indirect: By Trust) - Conversion
Common Stock
2010-01-27+94,455→ 697,067 total(indirect: By LLC) - Sale
Common Stock
2010-01-27$13.00/sh−637,253$8,284,289→ 691,741 total(indirect: By LLC) - Conversion
Series A Preferred Stock
2010-01-27−618,472→ 0 total(indirect: By Trust)→ Common Stock (618,472 underlying) - Conversion
Series B Preferred Stock
2010-01-27−94,455→ 0 total(indirect: By LLC)→ Common Stock (94,455 underlying) - Conversion
Common Stock
2010-01-27−631,927→ 0 total(indirect: By LLC)→ Common Stock (631,927 underlying) - Other
Employee Stock Option
2010-01-27+96,010→ 96,010 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (96,010 underlying) - Conversion
Series A Preferred Stock
2010-01-27−602,612→ 0 total(indirect: By LLC)→ Common Stock (602,612 underlying) - Other
Employee Stock Option
2010-01-27−96,010→ 0 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (96,010 underlying)
Footnotes (7)
- [F1]Series A Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
- [F2]Series B Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
- [F3]Reporting person was granted these shares of Restricted Stock in Cellu Parent Corporation on June 12, 2006, of which 75% had vested. Pursuant to the terms of the reorganization transactions that was consummated in connection with the Issuer's initial public offering and upon the closing of the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation Common Stock was exchanged for fully vested shares of Issuer Common Stock.
- [F4]Reporting person held an option to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions that was consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
- [F5]Upon the closing of the Issuer's initial public offering and on the date of the exchange, options to purchase 31,175 shares were fully vested and options for the remaining shares will vest as to 33.33% of the shares each year beginning on the first anniversary date of the closing of the Issuer's initial public offering.
- [F6]Reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest therein.
- [F7]Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.